{"transactions":[{"id":3816485,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":2,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":3,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":4,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":5,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":6,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":7,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":8,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":10,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T16:12:49.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":78677,"price":4.9159,"value":386768.2643,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement. Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,013,020 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1013020,"source":{"system":"sec-edgar","filing":"0001209191-18-051069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118051069/doc4.xml","form_type":"4"}},{"id":3816484,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":2,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":3,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":4,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":5,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":6,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":7,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":8,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":10,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T16:12:49.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":29137,"price":5.0059,"value":145856.9083,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement. Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,013,020 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1091697,"source":{"system":"sec-edgar","filing":"0001209191-18-051069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118051069/doc4.xml","form_type":"4"}},{"id":3816483,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":2,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":3,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":4,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":5,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":6,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":7,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":8,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":10,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T16:12:49.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":189754,"price":5.0597,"value":960098.3138,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement. Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,013,020 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1120834,"source":{"system":"sec-edgar","filing":"0001209191-18-051069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118051069/doc4.xml","form_type":"4"}},{"id":4071146,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-08T08:17:37.000Z","date":"2018-02-07","kind":"sale","acquired":false,"shares":150000,"price":7.1865,"value":1077975.0,"ownership":{"direct":false,"nature":"Through Ally Bridge LB Healthcare Master Fund Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ABG LB directly owns (i) 1,328,529 shares of common stock of the Issuer and (ii) warrants to purchase 432,432 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge LB Management Limited, as manager of ABG LB, (ii) Mr. Fan Yu, as a shareholder and director of Ally Bridge LB Management Limited, and (iii) Mr. Bin Li, as a shareholder and director of Ally Bridge LB Management Limited."}],"balance_after":1328529,"source":{"system":"sec-edgar","filing":"0001209191-18-008299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008299/doc4.xml","form_type":"4"}},{"id":4071145,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-08T08:17:37.000Z","date":"2018-02-06","kind":"sale","acquired":false,"shares":512912,"price":6.7541,"value":3464258.9392,"ownership":{"direct":false,"nature":"Through Ally Bridge LB Healthcare Master Fund Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ABG LB directly owns (i) 1,328,529 shares of common stock of the Issuer and (ii) warrants to purchase 432,432 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge LB Management Limited, as manager of ABG LB, (ii) Mr. Fan Yu, as a shareholder and director of Ally Bridge LB Management Limited, and (iii) Mr. Bin Li, as a shareholder and director of Ally Bridge LB Management Limited."}],"balance_after":1478529,"source":{"system":"sec-edgar","filing":"0001209191-18-008299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008299/doc4.xml","form_type":"4"}},{"id":4073001,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T08:35:48.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":16973,"price":8.0038,"value":135848.4974,"ownership":{"direct":false,"nature":"Through ABG Innovation-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Ally Bridge Group Innovation Capital Partners III, L.P. is the owner of the sole voting share of ABG Innovation-SO Limited, which directly owns 1,408,027 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1408027,"source":{"system":"sec-edgar","filing":"0001209191-18-008030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008030/doc4.xml","form_type":"4"}},{"id":4073000,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T08:35:48.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":37483,"price":8.0038,"value":300006.4354,"ownership":{"direct":false,"nature":"Through ABG SRNE Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABG SRNE directly owns (i) 3,041,759 shares of common stock of the Issuer and (ii) warrants to purchase 972,972 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG SRNE, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":3041759,"source":{"system":"sec-edgar","filing":"0001209191-18-008030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008030/doc4.xml","form_type":"4"}},{"id":4072999,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T08:35:48.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":16265,"price":8.0038,"value":130181.807,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,310,588 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1310588,"source":{"system":"sec-edgar","filing":"0001209191-18-008030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008030/doc4.xml","form_type":"4"}},{"id":4084008,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-30","kind":"sale","acquired":false,"shares":57037,"price":7.6527,"value":436487.0499,"ownership":{"direct":false,"nature":"Through ABG Innovation-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Ally Bridge Group Innovation Capital Partners III, L.P. is the owner of the sole voting share of ABG Innovation-SO Limited, which directly owns 1,425,000 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1425000,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084007,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":17963,"price":7.6063,"value":136631.9669,"ownership":{"direct":false,"nature":"Through ABG Innovation-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Ally Bridge Group Innovation Capital Partners III, L.P. is the owner of the sole voting share of ABG Innovation-SO Limited, which directly owns 1,425,000 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1482037,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084006,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-30","kind":"sale","acquired":false,"shares":124333,"price":7.6527,"value":951483.1491,"ownership":{"direct":false,"nature":"Through ABG SRNE Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABG SRNE directly owns (i) 3,079,242 shares of common stock of the Issuer and (ii) warrants to purchase 972,972 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG SRNE, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":3079242,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084005,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":39667,"price":7.6063,"value":301719.1021,"ownership":{"direct":false,"nature":"Through ABG SRNE Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABG SRNE directly owns (i) 3,079,242 shares of common stock of the Issuer and (ii) warrants to purchase 972,972 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG SRNE, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":3203575,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084004,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-30","kind":"sale","acquired":false,"shares":53786,"price":7.6527,"value":411608.1222,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,326,853 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1326853,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084003,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":17214,"price":7.6063,"value":130934.8482,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,326,853 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1380639,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4348140,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":8,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T07:16:46.000Z","date":"2017-04-19","kind":"purchase","acquired":true,"shares":550000,"price":2,"value":1100000.0,"ownership":{"direct":false,"nature":"Through Ally Bridge LB Healthcare Master Fund Limited See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (ix) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG LB directly owns (i) 1,991,441 shares of common stock of the Issuer and (ii) warrants to purchase 432,432 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge LB Management Limited, as manager of ABG LB, (ii) Mr. Fan Yu, as a shareholder and director of Ally Bridge LB Management Limited, and (iii) Mr. Bin Li, as a shareholder and director of Ally Bridge LB Management Limited."}],"balance_after":1991441,"source":{"system":"sec-edgar","filing":"0001104659-17-025040","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917025040/a4.xml","form_type":"4"}},{"id":4351791,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":8,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T21:59:42.000Z","date":"2017-04-13","kind":"purchase","acquired":true,"shares":1500000,"price":2,"value":3000000.0,"ownership":{"direct":false,"nature":"Through ABG Innovation-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited (\"ABG Innovation\"), a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"ABG Innovation directly owns 1,500,000 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG Innovation, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1500000,"source":{"system":"sec-edgar","filing":"0001104659-17-023841","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917023841/a4.xml","form_type":"4"}},{"id":4351790,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":8,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T21:59:42.000Z","date":"2017-04-13","kind":"purchase","acquired":true,"shares":1000000,"price":2,"value":2000000.0,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited (\"ABG Innovation\"), a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,397,853 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1397853,"source":{"system":"sec-edgar","filing":"0001104659-17-023841","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917023841/a4.xml","form_type":"4"}},{"id":4480773,"issuer":{"id":112149,"kind":"organization","name":"BIOCEPT INC","symbol":"BIOC"},"owners":[{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":1,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":2,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":3,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":4,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-26T06:05:24.000Z","date":"2017-01-19","kind":"disposition_to_issuer","acquired":false,"shares":254893,"price":1.1,"value":280382.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ally Bridge LB Healthcare Master Fund Limited (the \"Master Fund\") directly held the disposed Common Stock and currently holds warrants to purchase 1,681,000 shares of Common Stock..  Ally Bridge LB Management Limited (\"LB Management\") owns the sole voting share of the Master Fund. Mr. Fan Yu and Mr. Bin Li are the shareholders and directors of LB Management. LB Management, by virtue of it being the holder of the sole voting share of the Master Fund, and each of Mr. Yu and Mr. Li, by virtue of being a shareholder and director of LB Management, may be deemed to have voting control and investment discretion over any shares held by the Master Fund. Each of LB Management, Mr. Yu and Mr. Li disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest therein, if any."},{"field":"security","element":"securityTitle","label":"F2","text":"(continued from footnote 1) This Form 4 shall not be deemed an admission that any of them are the beneficial owners of, or have any pecuniary interest in, such securities for any purposes. By virtue of the transactions described in that certain statement on Schedule 13D/A filed in January 2017, by the Reporting Persons, pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), the Reporting Persons may, based on facts described elsewhere in the Schedule 13D, be considered to be a \"group\";  however,  neither the filing of this Form 4 nor any of its contents shall be deemed to constitute an admission by such persons that such a group exists."},{"field":"security","element":"securityTitle","label":"F3","text":"All 1,681,000 shares of Common Stock held by the Master Fund were disposed in a series of sales of the Common Stock on January 17, 2017, January 18, 2017 and January 19, 2017.  The Master Fund still holds warrants to purchase 1,681,000 shares of Common Stock.  The warrants held by the Master Fund represent 8.76% of the Common Stock, calculated based on 19,180,397 shares of Commons Stock, which is the total of (i) 17,499,397 shares of the Issuer's Common Stock outstanding as of November 4, 2016, as reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2016 filed with the SEC on November 10, 2016; and (ii) 1,681,000 shares of Common Stock issuable upon exercise of warrants held by the Master Fund."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1044378/000089924317001973/doc4.xml","form_type":"4"}},{"id":4480772,"issuer":{"id":112149,"kind":"organization","name":"BIOCEPT INC","symbol":"BIOC"},"owners":[{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":1,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":2,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":3,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":4,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-26T06:05:24.000Z","date":"2017-01-18","kind":"disposition_to_issuer","acquired":false,"shares":549708,"price":1.1,"value":604678.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ally Bridge LB Healthcare Master Fund Limited (the \"Master Fund\") directly held the disposed Common Stock and currently holds warrants to purchase 1,681,000 shares of Common Stock..  Ally Bridge LB Management Limited (\"LB Management\") owns the sole voting share of the Master Fund. Mr. Fan Yu and Mr. Bin Li are the shareholders and directors of LB Management. LB Management, by virtue of it being the holder of the sole voting share of the Master Fund, and each of Mr. Yu and Mr. Li, by virtue of being a shareholder and director of LB Management, may be deemed to have voting control and investment discretion over any shares held by the Master Fund. Each of LB Management, Mr. Yu and Mr. Li disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest therein, if any."},{"field":"security","element":"securityTitle","label":"F2","text":"(continued from footnote 1) This Form 4 shall not be deemed an admission that any of them are the beneficial owners of, or have any pecuniary interest in, such securities for any purposes. By virtue of the transactions described in that certain statement on Schedule 13D/A filed in January 2017, by the Reporting Persons, pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), the Reporting Persons may, based on facts described elsewhere in the Schedule 13D, be considered to be a \"group\";  however,  neither the filing of this Form 4 nor any of its contents shall be deemed to constitute an admission by such persons that such a group exists."},{"field":"security","element":"securityTitle","label":"F3","text":"All 1,681,000 shares of Common Stock held by the Master Fund were disposed in a series of sales of the Common Stock on January 17, 2017, January 18, 2017 and January 19, 2017.  The Master Fund still holds warrants to purchase 1,681,000 shares of Common Stock.  The warrants held by the Master Fund represent 8.76% of the Common Stock, calculated based on 19,180,397 shares of Commons Stock, which is the total of (i) 17,499,397 shares of the Issuer's Common Stock outstanding as of November 4, 2016, as reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2016 filed with the SEC on November 10, 2016; and (ii) 1,681,000 shares of Common Stock issuable upon exercise of warrants held by the Master Fund."}],"balance_after":254893,"source":{"system":"sec-edgar","filing":"0000899243-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1044378/000089924317001973/doc4.xml","form_type":"4"}},{"id":4480771,"issuer":{"id":112149,"kind":"organization","name":"BIOCEPT INC","symbol":"BIOC"},"owners":[{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":1,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":2,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":3,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":4,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-26T06:05:24.000Z","date":"2017-01-17","kind":"disposition_to_issuer","acquired":false,"shares":876399,"price":1.1,"value":964038.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ally Bridge LB Healthcare Master Fund Limited (the \"Master Fund\") directly held the disposed Common Stock and currently holds warrants to purchase 1,681,000 shares of Common Stock..  Ally Bridge LB Management Limited (\"LB Management\") owns the sole voting share of the Master Fund. Mr. Fan Yu and Mr. Bin Li are the shareholders and directors of LB Management. LB Management, by virtue of it being the holder of the sole voting share of the Master Fund, and each of Mr. Yu and Mr. Li, by virtue of being a shareholder and director of LB Management, may be deemed to have voting control and investment discretion over any shares held by the Master Fund. Each of LB Management, Mr. Yu and Mr. Li disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest therein, if any."},{"field":"security","element":"securityTitle","label":"F2","text":"(continued from footnote 1) This Form 4 shall not be deemed an admission that any of them are the beneficial owners of, or have any pecuniary interest in, such securities for any purposes. By virtue of the transactions described in that certain statement on Schedule 13D/A filed in January 2017, by the Reporting Persons, pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), the Reporting Persons may, based on facts described elsewhere in the Schedule 13D, be considered to be a \"group\";  however,  neither the filing of this Form 4 nor any of its contents shall be deemed to constitute an admission by such persons that such a group exists."},{"field":"security","element":"securityTitle","label":"F3","text":"All 1,681,000 shares of Common Stock held by the Master Fund were disposed in a series of sales of the Common Stock on January 17, 2017, January 18, 2017 and January 19, 2017.  The Master Fund still holds warrants to purchase 1,681,000 shares of Common Stock.  The warrants held by the Master Fund represent 8.76% of the Common Stock, calculated based on 19,180,397 shares of Commons Stock, which is the total of (i) 17,499,397 shares of the Issuer's Common Stock outstanding as of November 4, 2016, as reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2016 filed with the SEC on November 10, 2016; and (ii) 1,681,000 shares of Common Stock issuable upon exercise of warrants held by the Master Fund."}],"balance_after":804601,"source":{"system":"sec-edgar","filing":"0000899243-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1044378/000089924317001973/doc4.xml","form_type":"4"}},{"id":4495590,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":8,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-09T08:33:28.000Z","date":"2017-01-05","kind":"other","acquired":true,"shares":3243242,"ownership":{"direct":false,"nature":"Through ABG SRNE Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\").  According to a Form 8-K filing by the Issuer on January 5, 2017, the Issuer consummated a transaction that involved (i) the cancellation of warrants to purchase an aggregate of 1,137,316 shares of Common Stock (the \"Warrants\") and cancellation of secured promissory notes in an aggregate principal amount of $53,502,315 that were issued to the Issuer, of which $43,502,315 in aggregate principal amount was outstanding as of December 31, 2016 (the \"Notes\") and (ii) forfeiture of 7,838,259 shares of Common Stock (the \"Shares\") which were returned to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the forfeiture of the Shares and the cancellation of the Warrants and Notes, the Issuer had 58,721,115 Shares outstanding and warrants to purchase an aggregate of 7,070,314 shares of Common Stock outstanding.  The Issuer now has 50,882,856 Shares outstanding and warrants to purchase an aggregate of 5,932,998 shares of Common Stock outstanding.  As a result of this transaction, the Reporting Persons' (defined below) collective ownership of the Issuer's securities have increased."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (ix) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABG SRNE directly owns (i) 3,243,242 shares of common stock of the Issuer and (ii) warrants to purchase 972,972 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG SRNE, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":3243242,"source":{"system":"sec-edgar","filing":"0001104659-17-001383","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917001383/a4.xml","form_type":"4"}},{"id":4495589,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":8,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-09T08:33:28.000Z","date":"2017-01-05","kind":"other","acquired":true,"shares":1441441,"ownership":{"direct":false,"nature":"Through Ally Bridge LB Healthcare Master Fund Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\").  According to a Form 8-K filing by the Issuer on January 5, 2017, the Issuer consummated a transaction that involved (i) the cancellation of warrants to purchase an aggregate of 1,137,316 shares of Common Stock (the \"Warrants\") and cancellation of secured promissory notes in an aggregate principal amount of $53,502,315 that were issued to the Issuer, of which $43,502,315 in aggregate principal amount was outstanding as of December 31, 2016 (the \"Notes\") and (ii) forfeiture of 7,838,259 shares of Common Stock (the \"Shares\") which were returned to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the forfeiture of the Shares and the cancellation of the Warrants and Notes, the Issuer had 58,721,115 Shares outstanding and warrants to purchase an aggregate of 7,070,314 shares of Common Stock outstanding.  The Issuer now has 50,882,856 Shares outstanding and warrants to purchase an aggregate of 5,932,998 shares of Common Stock outstanding.  As a result of this transaction, the Reporting Persons' (defined below) collective ownership of the Issuer's securities have increased."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (ix) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ABG LB directly owns (i) 1,441,441 shares of common stock of the Issuer and (ii) warrants to purchase 432,432 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge LB Management Limited, as manager of ABG LB, (ii) Mr. Fan Yu, as a shareholder and director of Ally Bridge LB Management Limited, and (iii) Mr. Bin Li, as a shareholder and director of Ally Bridge LB Management Limited."}],"balance_after":1441441,"source":{"system":"sec-edgar","filing":"0001104659-17-001383","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917001383/a4.xml","form_type":"4"}},{"id":4495588,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":8,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-09T08:33:28.000Z","date":"2017-01-05","kind":"other","acquired":true,"shares":397853,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\").  According to a Form 8-K filing by the Issuer on January 5, 2017, the Issuer consummated a transaction that involved (i) the cancellation of warrants to purchase an aggregate of 1,137,316 shares of Common Stock (the \"Warrants\") and cancellation of secured promissory notes in an aggregate principal amount of $53,502,315 that were issued to the Issuer, of which $43,502,315 in aggregate principal amount was outstanding as of December 31, 2016 (the \"Notes\") and (ii) forfeiture of 7,838,259 shares of Common Stock (the \"Shares\") which were returned to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the forfeiture of the Shares and the cancellation of the Warrants and Notes, the Issuer had 58,721,115 Shares outstanding and warrants to purchase an aggregate of 7,070,314 shares of Common Stock outstanding.  The Issuer now has 50,882,856 Shares outstanding and warrants to purchase an aggregate of 5,932,998 shares of Common Stock outstanding.  As a result of this transaction, the Reporting Persons' (defined below) collective ownership of the Issuer's securities have increased."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (ix) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 397,853 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":397853,"source":{"system":"sec-edgar","filing":"0001104659-17-001383","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917001383/a4.xml","form_type":"4"}}]}